ALLO earnings: a positive outcome, +5.1%

On May 13, 2024, Allogene Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.1% in the window around the event. It had already run -27.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.